Yuta Liu
Overview
Explore the profile of Yuta Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin S, Liu Y, He G, Yang J, Zeng F, Lu Q, et al.
ACS Nano
. 2024 Sep;
18(39):26858-26871.
PMID: 39308426
The anti-PD-L1 and its bispecific antibodies have exhibited durable antitumor immunity but still elicit immunosuppression mainly caused by tumor-derived exosomes (TDEs), leading to difficulty in clinical transformation. Herein, engineered Nissle...
2.
Feng S, Zhang Y, Hou C, Liu Y, Gao Y, Song Y, et al.
Sci Adv
. 2024 Aug;
10(35):eadn8695.
PMID: 39196940
Despite the therapeutic benefits of insulin-pramlintide dual-hormone therapy in diabetes, its application potential has been limited due to a lack of efficient delivery routes. Here, we developed a temperature-responsive dual-hormone...
3.
Wang Y, Feng S, Wang X, Tao C, Liu Y, Wang Y, et al.
Lab Chip
. 2024 Jun;
24(14):3521-3527.
PMID: 38939907
Zeolitic imidazolate framework-8 (ZIF-8) encapsulating enzymatically active biomolecules has emerged as a novel biocompatible nanozyme and offers significant implications for bioanalysis of various biomarkers towards early diagnosis of severe diseases...
4.
Zeng F, Pan Y, Lu Q, Luan X, Qin S, Liu Y, et al.
Adv Healthc Mater
. 2024 Feb;
13(14):e2303683.
PMID: 38386961
Employing tumor whole cells for tumor immunotherapy is a promising tumor therapy proposed in the early stage, but its therapeutic efficacy is weakened by the methods of eliminating pathogenicity and...
5.
Feng S, Zhang Y, Gao Y, Liu Y, Wang Y, Han X, et al.
Angew Chem Int Ed Engl
. 2023 Oct;
62(50):e202313968.
PMID: 37884479
Macrophage phagocytosis of tumor cells has emerged as an attractive strategy for tumor therapy. Nevertheless, immunosuppressive M2 macrophages in the tumor microenvironment and the high expression of anti-phagocytic signals from...
6.
Wang Y, Gao Y, Pan Y, Zhou D, Liu Y, Yin Y, et al.
Acta Pharm Sin B
. 2023 Jul;
13(6):2483-2509.
PMID: 37425038
New drug discovery is under growing pressure to satisfy the demand from a wide range of domains, especially from the pharmaceutical industry and healthcare services. Assessment of drug efficacy and...